Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Towards a More Personalized Treatment of Dyslipidemias to Prevent Cardiovascular Disease.

Current cardiology reports - 25 May 2018

Hoffmann Michael M

Abstract excerpt

PURPOSE OF REVIEW: Today, statins are the first choice to lower LDL cholesterol and concomitantly the risk of atherosclerotic cardiovascular disease. There is a significant minority of statin-treated patients who are more susceptible to occasionally serious side effects that may increase morbidity and lead to compliance problems or the discontinuation of therapy. This review addresses the question of whether...

Topics

Join the communities discussing this publication.

Cardiovascular Diseases
Diabetes Mellitus, Type 2
Dyslipidemias
Genome-Wide Association Study
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Muscular Diseases

Pharmacogenomic Testing

Precision Medicine

Source

Identifiers

PMID: 29802474
DOI: 10.1007/s11886-018-0996-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Towards a More Personalized Treatment of Dyslipidemias to Prevent Cardiovascular Disease.PMID 29802474Read ↗

Genetics and personalized medicine--a role in statin therapy?Semantic proximity Read ↗

Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.Semantic proximity Read ↗

Statins personalized.Semantic proximity Read ↗

Genetic determinants of response to statins.Semantic proximity Read ↗

Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy.Semantic proximity Read ↗

Seventeen years of statin pharmacogenetics: a systematic review.Semantic proximity Read ↗

The pharmacogenomics of statins.Semantic proximity Read ↗

Genetic contribution to lipid target achievement with statin therapy: a prospective study.Semantic proximity Read ↗

Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.Semantic proximity Read ↗

When the same treatment has different response: The role of pharmacogenomics in statin therapySemantic proximity Read ↗

Impact of Pharmacogenetics on Efficacy and Safety of Statin Therapy for DyslipidemiaSemantic proximity Read ↗

[PERSONALIZED APPROACH TO LIPID-LOWERING THERAPY].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.